Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2025-12-25 @ 12:14 AM
NCT ID:
NCT00995358
Eligibility Criteria:
Inclusion Criteria:
DISEASE CHARACTERISTICS
* Locally advanced, recurrent or metastatic esophageal squamous cell carcinoma who had failed for the standard therapy
PATIENTS CHARACTERISTICS
* ECOG performance status 0-2
* Age≧ 20≦ 80years
* WBC≥ 2,000/mm³ Platelet count ≥ 75,000/mm³ Total bilirubin ≤ 2.0 x the institutional normal upper limits AST, ALT, ALP ≤ 2.5 x the institutional normal upper limits Creatinine ≤ 1.5 x the institutional normal upper limits
* No therapy 4 weeks prior to the initiation of the trial
* Able and willing to give valid written informed consent
Exclusion Criteria:
* Pregnancy (women of childbearing potential: Refusal or inability to use effective means of contraception)
* Breastfeeding
* Serious bleeding disorder
* Serious infections requiring antibiotics
* Concomitant treatment with steroids or immunosuppressing agent
* Decision of unsuitableness by principal investigator or physician-in-charge
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
80 Years
Study:
NCT00995358
Study Brief:
Protocol Section:
NCT00995358